Medicine and Dentistry
Randomized Controlled Trial
100%
Cost-Effectiveness Analysis
57%
Clozapine
50%
Early Psychosis
50%
Treatment-Resistant Schizophrenia
50%
Mental Health
50%
Quality Adjusted Life Year
40%
Health Care Cost
30%
Arm
30%
National Health Service
20%
Adverse Event
20%
Subgroup Analysis
10%
Patient Referral
10%
Early Intervention
10%
Quality of Life
7%
Antipsychotic
7%
Adverse Effect
7%
Nursing and Health Professions
Adolescent
100%
Meta Analysis
50%
Systematic Review
50%
Cost Effectiveness Analysis
50%
Mental Health
50%
Quality Adjusted Life Year
40%
Socialized Medicine
20%
Incremental Cost-Effectiveness Ratio
20%
Adverse Event
20%
Mental Health Care Personnel
12%
Embase
12%
Medline
12%
Cochrane Library
12%
Confidence Interval
12%
Depressive Disorder
12%
Clinical Effectiveness
10%
Randomization
10%
Patient Referral
10%
Early Intervention
10%
Psychology
Mental Health
58%
Psychosocial Intervention
50%
Meta-Analysis
50%
Systematic Review
50%
Ethnic Minority
50%
Mood
50%
Early Intervention
50%
Standardized Mean Difference
41%
Medline
8%
Depressive Disorder
8%
